November 2015

We have previously written about the proposed Novartis AG settlement relating its False Claims Act suit. The suit…

We previously wrote about the actions Congress is taking to "combat rising prescription drug prices," and the rhetoric…

Despite Congressional interest in delaying Stage 3 of the electronic health record Meaningful Use program and the AMA…

Background The House Energy & Commerce Committee's Health Subcommittee held a hearing on November 17, 2015, to discuss a…

As our readers know, from both their own experience and the articles written on our website, drug pricing is a hot issue right…

The Senate Finance Committee has been conducting an investigation into Physician Owned Distributorships (PODs), leading…

At this week's American Medical Association (AMA) House of Delegates meeting in Atlanta the AMA adopted recommendations…

The 2016 presidential race is fraught with hot-button issues, with each party and each candidate taking positions on…

Federal prosecutors in at least four states – Florida, California, Texas, and Mississippi – are ramping up…

Continuing medical education courses have been under attack lately, with skeptical writers making unsubstantiated claims…